Zentalis Pharmaceuticals, Inc.

NASDAQ:ZNTL

3.81 (USD) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Operating Activities:
Net Income -88.27710.068-60.917-55.54-112.564-63.262-54.984-54.5-68.392-59.237-50.095-10.492-55.062-50.444-40.356-34.665-27.292-16.235-14.546-12.572-10.597-8.663
Depreciation & Amortization 0.3270.3240.3370.3480.3440.360.3590.3750.3480.3440.2090.1370.1190.0790.0330.0510.0380.0380.0410.0250.0240.021
Deferred Income Tax 00-4.1570-0.756-0.097-0.769-0.1250.074-0.0740.0366.3010.4880.5430.0170.110.4350.1090.040.2280.1270.32
Stock Based Compensation 12.71112.83313.8813.86713.34213.7339.61210.31716.76410.1478.4717.6569.9199.6917.8877.2497.6810.3290.2120.1550.1210.129
Change In Working Capital 14.099-16.30510.2684.779-5.164-4.0193.9839.6292.987-3.3472.36712.61-1.3212.9014.736.642-2.525-1.0031.1022.4043.494-0.493
Accounts Receivables 000000-0.0040.004000.104-0.1030.2430.169-0.295-0.0490.0660.001-0.090.270.3720.225
Change In Inventory 0000000000-0.8155.633-2.58-1.3570.265-0.988-3.746-1.05-0.675-0.449-0.154-0.23
Change In Accounts Payables 11.797-15.24910.3976.327-4.394-1.41116.1016.4524.599-0.5741.6067.4721.5313.3075.2587.8371.1590.0531.9682.4543.168-0.467
Other Working Capital 2.302-1.056-0.129-1.548-0.77-2.608-12.1143.173-1.612-2.7731.472-0.392-0.5150.782-0.498-0.158-0.004-0.007-0.1010.1290.108-0.021
Other Non Cash Items 27.569-30.164-0.01-2.11925.5234.0024.471.1055.1921.9711.991-49.702-0.256-0.2390.3320.049-0.37-0.109-0.04-0.228-0.127-0.32
Operating Cash Flow -35.139-51.974-40.599-38.665-79.275-49.283-37.329-33.199-43.027-50.196-37.021-33.49-46.113-37.469-27.357-20.564-22.033-16.871-13.191-9.988-6.958-9.006
Investing Activities:
Investments In Property Plant And Equipment -0.181-0.04-0.173-0.091-0.3190-0.16-1.66-0.278-0.45-2.191-2.661-0.819-0.436-0.661-0.041-0.025-0.031-0.036-0.107-0.168-0.041
Acquisitions Net 0.06500.0420.117-0.07300.012-0.0220.14200-14.3200-108.2360000000
Purchases Of Investments -19.394-10.115-95.987-264.11-125.206-63.879-125.984-129.601-198.322-79.254-83.223-202.473-23.378-54.434-96.899-166.849-137.23600000
Sales Maturities Of Investments 5471.754.1146.75198.457106114.25151.27956.599.5128.68178.01190.868.32887.9129000000
Other Investing Activites 0.06561.585-0.042-0.1170.0730.042-0.0120.022-0.14220.24645.458-14.3267.42213.894108.23629-137.23600000
Investing Cash Flow 34.4961.545-42.06-117.45172.93242.121-11.89420.018-142.119.79643.267-141.44366.60313.458-9.65-137.89-137.261-0.031-0.036-0.107-0.168-0.041
Financing Activities:
Debt Repayment 0000000000000000000000
Common Stock Issued 0.0090.248-235.680.309236.6210.37349.7410.589209.4551.25813.413166.254-0.3160-0.594155.899000000
Common Stock Repurchased 0-0.24100000000-1.146000-0.5940000000
Dividends Paid 0000000000000000000000
Other Financing Activities 0-0.241235.4430.309236.6210.3730.050.0010.2091.258-1.1460.316-0.3160-17.177155.899191.6613.474-0.05381.88300
Financing Cash Flow 0.0090.00700.309236.6210.37349.7410.589209.4551.25812.267166.57-0.3160-0.594155.899191.6613.474-0.05381.88300
Other Information:
Effect Of Forex Changes On Cash 0000000000000000000000
Net Change In Cash -0.649.578-82.713-155.807230.278-6.7890.518-12.59224.328-29.14218.513-8.36320.174-24.011-37.601-2.55532.366-3.428-13.2871.788-7.126-9.047
Cash At End Of Period 36.97637.61628.038113.378269.18538.90745.69645.17857.7733.44262.58444.07152.43432.2656.27193.87296.42764.06167.48980.7698.98116.107